cilta-cel effective in lenalidomide-refractory multiple myeloma
Published 1 year ago • 140 plays • Length 4:33Download video MP4
Download video MP3
Similar videos
-
1:45
cartitude-2 update: cilta-cel in relapsed and lenalidomide-refractory patients with multiple myeloma
-
8:16
results from cartitude-4: cilta-cel for lenalidomide-refractory multiple myeloma
-
7:25
cilta-cel continues to show promise as a treatment for progressive multiple myeloma
-
11:43
cartitude-4: cilta-cel vs standard of care pvd or dpd in lenalidomide-refractory multiple myeloma
-
3:51
treatment options for refractory/relapsed multiple myeloma
-
1:35
long-term efficacy and safety of cilta-cel in patients with relapsed/refractory multiple myeloma
-
3:07
cilta-cel in lenalidomide-refractory mm patients: updates from cohort a of the cartitude-2 trial
-
5:10
lenalidomide-refractory multiple myeloma
-
2:33
latest results from the cartitude-2 trial of cilta-cel in progressive multiple myeloma
-
1:17
efficacy & safety of standard of care cilta-cel in r/r multiple myeloma
-
1:22
managing lenalidomide-refractory myeloma patients
-
1:08
dr. yee on trials evaluating treatment in lenalidomide-refractory multiple myeloma
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
0:58
will cilta-cell be the next car t-cell approval in multiple myeloma?
-
4:17
ciltacabtagene autoleucel greatly reduces risk of disease progression in lenalidomide-refractory mm
-
3:59
addressing the unmet need for patients with lenalidomide-refractory multiple myeloma
-
2:17
cilta-cel: a paradigm shift in the treatment of multiple myeloma
-
0:55
the need to improve treatment options for patients with lenalidomide-refractory multiple myeloma
-
0:45
car t-cell therapy in lenalidomide-refractory multiple myeloma